Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-21

Clinical Trial Update: mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating hyperbaric oxygen therapy for persistent post-concussive symptoms after mild traumatic brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyperbaric Oxygen Therapy

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Traumatic Brain Injury With Brief Loss of Consciousness, Post-Concussion Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-11-21